Imaging Study for FdCyd and THU Cancer Treatment
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Head and Neck Neoplasms|Lung Neoplasms|Urinary Bladder Neoplasms|Breast Neoplasms
Interventions: DRUG: [F-18]-5-FLUORO-2'-DEOXYCYTIDINE|DRUG: Tetrahydrouridine intravenous (IV)|DRUG: Tetrahydrouridine (oral)|DIAGNOSTIC_TEST: Positron emission tomography (PET)/Computed tomography (CT)
Sponsor: National Cancer Institute (NCI)